Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy

Nicotine and Tobacco Research

Volumn 17, Issue 4, 2014, Pages 398-406

  Saladin, Michael E ^a,b   McClure, Erin A ^b   Baker, Nathaniel L ^b   Carpenter, Matthew J ^a,b   Ramakrishnan, Viswanathan ^b   Hartwell, Karen J ^b,c   Gray, Kevin M ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; NICOTINE PATCH; PLACEBO; PROGESTERONE; VARENICLINE; BENZAZEPINE DERIVATIVE; NICOTINE; NICOTINIC AGENT; QUINOXALINE DERIVATIVE;

ADULT; ARTICLE; BEHAVIOR ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CYCLING; DRUG BLOOD LEVEL; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE OF SMOKING URGES; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; TABLET; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; BLOOD; METABOLISM; MIDDLE AGED; PROCEDURES; TRANSDERMAL PATCH; WOMEN'S HEALTH;

ADOLESCENT; ADULT; BENZAZEPINES; ESTRADIOL; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PROGESTERONE; QUINOXALINES; SMOKING CESSATION; TRANSDERMAL PATCH; TREATMENT OUTCOME; VARENICLINE; WOMEN'S HEALTH;

EID: 84929088132     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu262     Document Type: Article

References (61)

1. Fortmann SP, Killen JD. Who shall quit? Comparison of volunteer and population-based recruitment in two minimal-contact smoking cessation studies. Am J Epidemiol. 1994;140:39-51.
2. Husten CG, Shelton DM, Chrismon JH, Lin YC, Mowery P, Powell FA. Cigarette smoking and smoking cessation among older adults: United States, 1965-94. Tob Control. 1997;6:175-180.
3. Ward KD, Klesges RC, Zbikowski SM, Bliss RE, Garvey AJ. Gender differences in the outcome of an unaided smoking cessation attempt. Addict Behav. 1997;22:521-533.
4. Bjornson W, Rand C, Connett JE, et al. Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health. 1995;85:223-230.
5. COMMIT. Community Intervention Trial for Smoking Cessation (COMMIT): I. cohort results from a four-year community intervention. Am J Public Health. 1995;85:183-192.
6. Davis LJ Jr, Hurt RD, Offord KP, Lauger GG, Morse RM, Bruce BK. Selfadministered Nicotine-Dependence Scale (SANDS): item selection, reliability estimation, and initial validation. J Clin Psychol. 1994;50:918-930.
7. Killen JD, Fortmann SP, Newman B, Varady A. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol. 1990;58:85-92.
8. Perkins KA, Scott J. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine Tob Res. 2008;10:1245-1250.
9. Scharf D, Shiffman S. Are there gender differences in smoking cessation, with and without bupropion? Pooled-and meta-analyses of clinical trials of Bupropion SR. Addiction. 2004;99:1462-1469.
10. Wetter DW, Fiore MC, Young TB, McClure JB, de Moor CA, Baker TB. Gender differences in response to nicotine replacement therapy: objective and subjective indexes of tobacco withdrawal. Exp Clin Psychopharmacol. 1999;7:135-144.
11. Wetter DW, Kenford SL, Smith SS, Fiore MC, Jorenby DE, Baker TB. Gender differences in smoking cessation. J Consult Clin Psychol. 1999;67:555-562.
12. US Dept of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.
13. US Dept of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
14. Anker JJ, Carroll ME. The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research. Neurosci Biobehav Rev. 2010;35:315-333.
15. Carroll ME, Anker JJ. Sex differences and ovarian hormones in animal models of drug dependence. Horm Behav. 2010;58:44-56.
16. Hudson A, Stamp JA. Ovarian hormones and propensity to drug relapse: a review. Neurosci Biobehav Rev. 2011;35:427-436.
17. Lynch WJ, Roth ME, Carroll ME. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology (Berl). 2002;164:121-137.
18. Sofuoglu M, Babb DA, Hatsukami DK. Progesterone treatment during the early follicular phase of the menstrual cycle: effects on smoking behavior in women. Pharmacol Biochem Be. 2001;69:299-304.
19. Sofuoglu M, Mitchell E, Mooney M. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Hum Psychopharmacol. 2009;24:559-564.
20. Sofuoglu M, Mouratidis M, Mooney M. Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology. 2011;36:123-132.
21. DeVito EE, Herman AI, Waters AJ, Valentine GW, Sofuoglu M. Subjective, physiological, and cognitive responses to intravenous nicotine: effects of sex and menstrual cycle phase. Neuropsychopharmacology. 2014;39:1431-1440.
22. Schiller CE, Saladin ME, Gray KM, Hartwell KJ, Carpenter MJ. Association between ovarian hormones and smoking behavior in women. Exp Clin Psychopharmacol. 2012;20:251-257.
23. Carpenter MJ, Saladin ME, Leinbach AS, Larowe SD, Upadhyaya HP. Menstrual phase effects on smoking cessation: a pilot feasibility study. J Womens Health. 2008;17:293-301.
24. Franklin TR, Ehrman R, Lynch KG, et al. Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health. 2008;17:287-292.
25. Allen SS, Bade T, Center B, Finstad D, Hatsukami D. Menstrual phase effects on smoking relapse. Addiction. 2008;103:809-821.
26. Mazure CM, Toll B, McKee SA, Wu R, O'Malley SS. Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion. Drug Alcohol Depend. 2011;114:68-72.
27. Allen SS, Allen AM, Lunos S, Hatsukami DK. Patterns of self-selected smoking cessation attempts and relapse by menstrual phase. Addict Behav. 2009;34:928-931.
28. Gandara BK, Leresche L, Mancl L. Patterns of salivary estradiol and progesterone across the menstrual cycle. Ann N Y Acad Sci. 2007;1098: 446-450.
29. Gray KM, McClure EA, Baker NL, Hartwell KJ, Carpenter MJ, Saladin ME. A short-term double-blind trial of varenicline versus nicotine patch for smoking cessation in women. Addiction. Under review.
30. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29-38.
31. Piasecki TM. Relapse to smoking. Clin Psychol Rev. 2006;26:196-215.
32. Heatherton T, Kozlowski L, Frecker R, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86:1119-1127.
33. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001;3:7-16.
34. Robinson SM, Sobell LC, Sobell MB, Leo GI. Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use. Psychol Addict Behav. 2014;28:154-162.
35. Sobell LC, Sobell MB, Leo GI, Cancilla A. Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict. 1988;83:393-402.
36. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
37. Pan W. Akaike's information criterion in generalized estimating equations. Biometrics. 2001;57:120-125.
38. Carpenter MJ, Upadhyaya HP, LaRowe SD, Saladin ME, Brady KT. Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine Tob Res. 2006;8:627-638.
39. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979;74:829-836.
40. Cleveland WS, Devlin SJ. Locally-weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc. 1988;83:596-610.
41. Bauld L, Ferguson J, McEwen A, Hiscock R. Evaluation of a dropin rolling-group model of support to stop smoking. Addiction. 2012;107:1687-1695.
42. Brose LS, West R, McDermott MS, Fidler JA, Croghan E, McEwen A. What makes for an effective stop-smoking service? Thorax. 2011;66:924-926.
43. Kralikova E, Kmetova A, Stepankova L, Zvolska K, Davis R, West R. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy. Addiction. 2013;108:1497-1502.
44. Stapleton JA, Watson L, Spirling LI, et al. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction. 2008;103:146-154.
45. Balen A. Reproductive Endocrinology for the MRCOG and Beyond. 2nd ed. London: Royal College of Obstetricians and Gynaecologists; 2007.
46. Guyton AC, Hall JE. Textbook of Medical Physiology. 10th ed. Philadelphia, PA: Saunders; 2000.
47. Laycock J, Meeran K. Integrative Endocrinology. Chichester, UK: Wiley; 2012.
48. Starr C, McMillan B. Human Biology. 7th ed. Belmont, CA: Thomson Brooks/Cole; 2007.
49. Lesage MG, Keyler DE, Burroughs D, Pentel PR. Effects of pregnancy on nicotine self-administration and nicotine pharmacokinetics in rats. Psychopharmacology (Berl). 2007;194:413-421.
50. Lynch WJ. Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats. Pharmacol Biochem Behav. 2009;94:43-50.
51. Festa ED, Quinones-Jenab V. Gonadal hormones provide the biological basis for sex differences in behavioral responses to cocaine. Horm Behav. 2004;46:509-519.
52. Hu M, Crombag HS, Robinson TE, Becker JB. Biological basis of sex differences in the propensity to self-administer cocaine. Neuropsychopharmacology. 2004;29:81-85.
53. Jackson LR, Robinson TE, Becker JB. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology. 2006;31:129-138.
54. Larson EB, Anker JJ, Gliddon LA, Fons KS, Carroll ME. Effects of estrogen and progesterone on the escalation of cocaine self-administration in female rats during extended access. Exp Clin Psychopharmacol. 2007;15:461-471.
55. Larson EB, Carroll ME. Estrogen receptor beta, but not alpha, mediates estrogen's effect on cocaine-induced reinstatement of extinguished cocaine-seeking behavior in ovariectomized female rats. Neuropsychopharmacology. 2007;32:1334-1345.
56. Larson EB, Roth ME, Anker JJ, Carroll ME Effect of short-vs. long-term estrogen on reinstatement of cocaine-seeking behavior in female rats. Pharmacol Biochem Be. 2005;82:98-108.
57. Yang H, Zhao W, Hu M, Becker JB. Interactions among ovarian hormones and time of testing on behavioral sensitization and cocaine self-administration. Behav Brain Res. 2007;184:174-184.
58. Anker JJ, Larson EB, Gliddon LA, Carroll ME. Effects of progesterone on the reinstatement of cocaine-seeking behavior in female rats. Exp Clin Psychopharmacol. 2007;15:472-480.
59. Evans SM, Foltin RW. Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates? Horm Behav. 2010;58:13-21.
60. Souza MF, Couto-Pereira NS, Freese L, et al. Behavioral effects of endogenous or exogenous estradiol and progesterone on cocaine sensitization in female rats. Braz J Med Biol Res. 2014;47:505-514.
61. Russo SJ, Festa ED, Fabian SJ, et al. Gonadal hormones differentially modulate cocaine-induced conditioned place preference in male and female rats. Neuroscience. 2003;120:523-533.